Clinical significance of human epididymis protein 4 (HE4), cancer antigen 125 (CA125), the risk of ovarian malignancy algorithm (ROMA), and Copenhagen index (CPH-I) for the diagnosis of endometrial carcinoma

Vesselina Koleva; Sevim Shefket; Snezhana Stoencheva

A 512

Детайли

Източник

Folia Medica

Местоиздаване

Plovdiv

Година на издаване

2025

Пор.№

Класификационен индекс

УДК	Значение
616-074/-078	Лабораторна диагностика. Клинична лаборатория
618-006	Тумори на женските полови органи

Том

Ключови думи

Автори от МУ - Пловдив

Допълнителна информация

ISSN: 0204-8043
Системен №: 34521
Тематични рубрики: Акушерство. Гинекология, Клинична лаборатория

Действия

APA Chicago / Turabian (16th edition) Harvard MLA (7th edition)

Koleva, V., Shefket, S., Stoencheva, S. Clinical significance of human epididymis protein 4 (HE4), cancer antigen 125 (CA125), the risk of ovarian malignancy algorithm (ROMA), and Copenhagen index (CPH-I) for the diagnosis of endometrial carcinoma, , 2025.

Koleva, V., Shefket, S., Stoencheva, S. . Clinical significance of human epididymis protein 4 (HE4), cancer antigen 125 (CA125), the risk of ovarian malignancy algorithm (ROMA), and Copenhagen index (CPH-I) for the diagnosis of endometrial carcinoma. Plovdiv: , 2025.

Koleva, V., Shefket, S., Stoencheva, S. (2025) Clinical significance of human epididymis protein 4 (HE4), cancer antigen 125 (CA125), the risk of ovarian malignancy algorithm (ROMA), and Copenhagen index (CPH-I) for the diagnosis of endometrial carcinoma, Plovdiv:

Koleva, V., Shefket, S., & Stoencheva, S. (2025). Clinical significance of human epididymis protein 4 (HE4), cancer antigen 125 (CA125), the risk of ovarian malignancy algorithm (ROMA), and Copenhagen index (CPH-I) for the diagnosis of endometrial carcinoma. Folia Medica. Plovdiv: 67 (1),